Can scotomas be temporary after peripheral laser photocoagulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Scotomas After Peripheral Laser Photocoagulation

Yes, scotomas after peripheral laser photocoagulation can be temporary, with gradual reduction in size or intensity occurring over a 6-12 month period, though some may persist permanently depending on treatment parameters and location. 1

Characteristics of Laser-Induced Scotomas

Laser photocoagulation intentionally destroys retinal tissue to achieve therapeutic effects, with scotomas being an anticipated side effect rather than a complication according to the American Academy of Ophthalmology 1. The nature of these scotomas varies based on several factors:

Factors Affecting Scotoma Persistence

  1. Treatment Location:

    • Peripheral scotomas are generally less symptomatic than those closer to the fovea 1
    • Proximity to the fovea (within 500μm) significantly increases the risk of persistent, symptomatic scotomas 1
  2. Energy Settings:

    • Higher energy settings cause more permanent damage and potentially more persistent scotomas 1
    • Careful control of power settings (lower than 20-90 W) and wavelength range (448-514.5 nm) minimizes damage to surrounding tissues 1
  3. Laser Technique:

    • Conventional threshold photocoagulation carries higher risk of persistent scotomas 1
    • Subthreshold diode laser and micropulse laser techniques show better functional outcomes with reduced risk of persistent scotomas 1, 2

Timeline for Scotoma Resolution

The American Academy of Ophthalmology indicates that conventional photocoagulation-induced "symptomatic paracentral scotomas" may persist but can show gradual reduction in size or intensity over 6-12 months 1. This is particularly noted in patients undergoing photocoagulation for conditions like diabetic macular edema.

Early research by Patz et al. (1975) demonstrated that extensive argon laser photocoagulation resulted in various visual field changes, including discrete scotomata in 11 of 24 patients, suggesting that some scotomas may persist 3. However, this older study did not specifically track the temporary nature of these defects over time.

Modern Approaches to Minimize Scotomas

More recent evidence supports using techniques that reduce the risk of persistent scotomas:

  • Subthreshold (invisible) diode laser modified grid photocoagulation has been shown to reduce/eliminate paracentral scotomas over time, with no post-treatment subjective complaints of increased paracentral scotomas in studied patients 2

  • Micropulse laser technique can significantly reduce paracentral scotomas over time 1

Monitoring and Assessment

The American Academy of Ophthalmology recommends:

  • Initial evaluation 3-4 months after photocoagulation, including visual field testing, OCT imaging, contrast sensitivity testing, and Amsler grid screening for laser-related scotomas 1

  • Setting appropriate patient expectations regarding the timeline for potential improvement (6-12 months) 1

Clinical Implications and Recommendations

When performing peripheral laser photocoagulation:

  • Use minimum effective energy levels and careful control of power settings 1
  • Consider subthreshold or micropulse techniques when appropriate to minimize scotoma risk 1, 2
  • Inform patients that scotomas may occur but can potentially improve over 6-12 months 1
  • Schedule follow-up evaluations to monitor for scotoma resolution and other potential complications 1

Caution and Pitfalls

  • Avoid treating within 500μm of the fovea when possible, as this significantly increases the risk of permanent, symptomatic scotomas 1
  • Be aware that laser scar expansion can occur after treatment (observed in 72.7% of cases in one study), potentially causing secondary retinal dysfunction and relative scotomas even after initially successful treatment 4
  • Remember that while peripheral scotomas are generally less symptomatic, they may still affect functional vision, particularly if extensive treatment is required 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.